Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study.

Mekky, Mohamed A; Sayed, Hani I; Abdelmalek, Mohamed O; Saleh, Medhat A; Osman, Osman A; Osman, Heba A; Morsy, Khairy H; Hetta, Helal F

Mekky, Mohamed A; Sayed, Hani I; Abdelmalek, Mohamed O; Saleh, Medhat A; Osman, Osman A; Osman, Heba A; Morsy, Khairy H; Hetta, Helal F.

Afiliação

Mekky MA; Department of Tropical Medicine and Gastroenterology, Assiut University Hospital, Assiut, Egypt.
Sayed HI; Center for Management of Viral Hepatitis, Ministry of Health, Assiut, Egypt.
Abdelmalek MO; Department of Tropical Medicine and Gastroenterology, Assiut University Hospital, Assiut, Egypt.
Saleh MA; Department of Public Health and Community Medicine, Assiut University, Assiut, Egypt.
Osman OA; Department of Tropical Medicine and Gastroenterology, Assiut University Hospital, Assiut, Egypt.
Osman HA; Department of Tropical Medicine and Gastroenterology, South Valley University Hospital, Qena, Egypt.
Morsy KH; Department of Tropical Medicine and Gastroenterology, Sohag University Hospital, Sohag, Egypt.
Hetta HF; Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt, helal.hetta@uc.edu.

Infect Drug Resist ; 12: 273-279, 2019.

Article em En | MEDLINE | ID: mdl-30774394

Palavras-chave

Direct acting; Occult; Sofosbuvir; hepatitis C

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Infect Drug Resist Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google